2023 ASCO Oral Presentation by Dr. Andrew Armstrong
Learn about the development and validation of an AI-derived digital pathology-based biomarker to predict benefit of long-term [...]
Mack Roach, MD, FASTRO, FASCO
Dr. Roach discusses how the performance of the multimodal artificial intelligence (MMAI)-derived prognostic biomarker is comp [...]
Daniel Spratt, MD
Dr. Spratt discusses how an MMAI-derived predictive biomarker is able to discriminate between patients with intermediate-risk [...]
Osama Mohamad, MD
Dr. Mohamad discusses the development and validation of a multimodal artificial intelligence (MMAI)-derived prognostic biomar [...]
Florida medical tech company launches novel AI test for...
ArteraAI’s ‘first-ever predictive test’ helps doctors choose personalized treatment for patients Fox News Article
Can Artificial Intelligence Help Diagnose Prostate Cancer?
AI may be a medical game-changer, with the power of machine learning advancing the efficacy of prostate cancer biopsies and m [...]
Andre Esteva of ArteraAI: 5 Things I Wish Someone...
Medium’s Doug Noll spoke with the CEO of ArteraAI, Andre Esteva, to discuss his path from Stanford University to founding fou [...]
ArteraAI and ACS form collaboration to use AI for...
ArteraAI and the American Cancer Society formed a collaboration focused on the development of AI-driven cancer therapy person [...]
ArteraAI and American Cancer Society Announce New Relationship
ArteraAI, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, and the American [...]